Blueberries Medical Reports Q1-2023
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), a leading player in the cannabis industry (together the “Company” or “Blueberries“) is thrilled to announce its exceptional financial and business performance for the first quarter ended March 31, 2023. The company has demonstrated remarkable growth, doubling its revenue from the comparative period in 2022. Blueberries has filed today its unaudited condensed interim consolidated financial statements and related management’s discussion and analysis, both of which are available on Blueberries’ profile at www.sedar.com. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.